Medpace Holdings Gross Margin 2014-2025 | MEDP

Current and historical gross margin for Medpace Holdings (MEDP) over the last 10 years. The current gross profit margin for Medpace Holdings as of December 31, 2025 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Medpace Holdings Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-12-31 $2.53B $1.80B 71.07%
2025-09-30 $2.36B $1.64B 69.56%
2025-06-30 $2.23B $1.53B 68.50%
2025-03-31 $2.16B $1.47B 68.10%
2024-12-31 $2.11B $1.43B 67.71%
2024-09-30 $2.07B $1.39B 67.29%
2024-06-30 $2.03B $1.36B 66.98%
2024-03-31 $1.96B $1.30B 66.46%
2023-12-31 $1.89B $1.25B 66.15%
2023-09-30 $1.78B $1.17B 65.47%
2023-06-30 $1.67B $1.09B 64.85%
2023-03-31 $1.56B $1.00B 64.11%
2022-12-31 $1.46B $0.93B 63.36%
2022-09-30 $1.38B $0.86B 62.69%
2022-06-30 $1.29B $0.80B 62.00%
2022-03-31 $1.21B $0.75B 61.70%
2021-12-31 $1.14B $0.70B 61.42%
2021-09-30 $1.09B $0.68B 62.16%
2021-06-30 $1.03B $0.64B 62.26%
2021-03-31 $0.96B $0.59B 61.57%
2020-12-31 $0.93B $0.57B 61.66%
2020-09-30 $0.90B $0.55B 61.05%
2020-06-30 $0.88B $0.54B 61.11%
2020-03-31 $0.89B $0.56B 62.40%
2019-12-31 $0.86B $0.54B 62.72%
2019-09-30 $0.82B $0.52B 63.18%
2019-06-30 $0.79B $0.50B 63.87%
2019-03-31 $0.74B $0.48B 64.15%
2018-12-31 $0.70B $0.45B 64.35%
2018-09-30 $0.63B $0.39B 61.76%
2018-06-30 $0.56B $0.33B 58.53%
2018-03-31 $0.49B $0.27B 54.97%
2017-12-31 $0.44B $0.22B 51.26%
2017-09-30 $0.43B $0.22B 51.85%
2017-06-30 $0.43B $0.22B 52.21%
2017-03-31 $0.43B $0.23B 52.91%
2016-12-31 $0.42B $0.22B 53.08%
2016-06-30 $0.30B $0.16B 53.69%
Sector Industry Market Cap Revenue
Medical Medical Services $12.148B $2.530B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $150.156B 27.25
HCA Healthcare (HCA) United States $120.821B 19.12
CVS Health (CVS) United States $99.843B 11.63
Elevance Health (ELV) United States $76.540B 11.49
Cencora (COR) United States $70.193B 22.08
Natera (NTRA) United States $28.526B 0.00
Labcorp Holdings (LH) United States $23.430B 17.86
DiDi Global (DIDIY) China $21.650B 20.00
Viatris (VTRS) United States $18.163B 6.77
EUROFINS SCIENT (ERFSF) Luxembourg $15.306B 0.00
BioMerieux (BMXMF) France $13.324B 0.00
Solventum (SOLV) United States $13.104B 12.72
Revvity (RVTY) United States $10.887B 18.94
CochLear (CHEOY) Australia $9.243B 0.00
Charles River Laboratories (CRL) United States $7.941B 15.29
ICON (ICLR) Ireland $7.510B 7.45
Sonic Healthcare (SKHHY) Australia $7.449B 0.00
BrightSpring Health Services (BTSG) United States $7.008B 41.78
HealthEquity (HQY) United States $6.312B 23.60
Avantor (AVTR) United States $6.275B 10.11
Bausch + Lomb (BLCO) Canada $6.034B 39.60
PACS (PACS) United States $5.922B 36.01
Caris Life Sciences,�Inc (CAI) United States $5.818B 0.00
Sotera Health (SHC) United States $4.864B 23.45
Alignment Healthcare (ALHC) United States $4.040B 0.00
Amplifon S.p.A (AMFPF) Italy $3.532B 20.61
Concentras Parent (CON) United States $3.017B 18.83
GeneDx Holdings (WGS) United States $2.606B 45.76
Establishment Labs Holdings (ESTA) United States $2.168B 0.00
Surgery Partners (SGRY) United States $2.000B 25.77
Organon (OGN) United States $1.921B 2.15
Pediatrix Medical (MD) United States $1.848B 11.04
Progyny (PGNY) United States $1.784B 35.07
Ardent Health (ARDT) United States $1.375B 4.49
InnovAge Holding (INNV) United States $1.134B 167.20
CareDx (CDNA) United States $1.010B 16.50
Teladoc Health (TDOC) United States $0.825B 0.00
GoodRx Holdings (GDRX) United States $0.740B 12.11
Nutex Health (NUTX) United States $0.705B 5.39
Omada Health (OMDA) United States $0.655B 0.00
Sonida Senior Living (SNDA) United States $0.641B 0.00
Embecta (EMBC) United States $0.602B 3.36
Enhabit (EHAB) United States $0.565B 25.36
COMPASS Pathways (CMPS) United Kingdom $0.558B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
SBC Medicals (SBC) United States $0.478B 8.79
CryoPort (CYRX) United States $0.418B 0.00
Strata Critical Medical (SRTA) United States $0.396B 0.00
QDM (QDMI) Hong Kong, SAR China $0.391B 82.38
Auna S.A (AUNA) Luxembourg $0.367B 5.90
So-Young (SY) China $0.328B 0.00
Shoulder Innovations (SI) United States $0.269B 0.00
Oncology Institute (TOI) United States $0.247B 0.00
Agilon Health (AGL) United States $0.150B 0.00
LifeMD (LFMD) United States $0.134B 0.00
Beauty Health (SKIN) United States $0.133B 0.00
Ascend Wellness Holdings (AAWH) United States $0.109B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
Biodesix (BDSX) United States $0.091B 0.00
Park Dental Partners (PARK) United States $0.078B 0.00
DocGo (DCGO) United States $0.073B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.041B 0.00
IceCure Medical (ICCM) Israel $0.039B 0.00
Pomdoctor - (POM) China $0.026B 0.00
Synergy CHC (SNYR) United States $0.018B 5.62
OSR Holdings (OSRH) United States $0.013B 0.00
Basel Medical Group (BMGL) Singapore $0.012B 0.00
Lifeward (LFWD) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
XWELL (XWEL) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00